{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-026232","form_type":"8-K","ticker":"ACET","cik":"0001720580","company_name":"Adicet Bio, Inc.","filed_at":"2022-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.877341+00:00","generated_at":"2026-06-21T07:36:32.718531+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Adicet Bio amends loan with PacWest, extends drawdown to 2024 and maturity to 2026","bullets":["Drawdown period for term loans extended by one year to April 19, 2024.","If company raises at least $60M in equity or partnership cash (excluding Regeneron) by Sept 30, 2023, interest-only period extends to Oct 19, 2024.","Final maturity of term loans extended one year to October 19, 2026.","Company must maintain lesser of $200M or 70% of combined deposit balances with PacWest.","Guarantor affirmed prior guaranty and security interest in substantially all assets except IP."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-026232","json":"https://secwatch.observer/filing/0000950170-22-026232.json","markdown":"https://secwatch.observer/filing/0000950170-22-026232.md","text":"https://secwatch.observer/filing/0000950170-22-026232.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1720580/000095017022026232/0000950170-22-026232-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1720580/000095017022026232/acet-20221202.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T07:36:32.718531+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f77aa7a0589a25347bf6327a2ab910c6d92b8189","claim":"Adicet Bio, Inc. amended Fifth Amendment to Loan and Security Agreement with Pacific Western Bank (\"PacWest\") (effective 2022-12-02).","evidence_excerpt":"On December 2, 2022 (the “Effective Date”), Adicet Therapeutics, Inc. (the “Subsidiary”), a Delaware corporation and wholly-owned subsidiary of Adicet Bio, Inc. (the “Guarantor”, and together with the Subsidiary, the “Company”), and Pacific Western Bank (“PacWest”) entered into a Fifth Amendment (the “Amendment”) to that certain Loan and Security Agreement, dated April 28, 2020, by and among the Subsidiary and PacWest (the “Agreement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017022026232/0000950170-22-026232-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Pacific Western Bank (\"PacWest\")"},{"label":"Effective","value":"2022-12-02"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}